The Latest Breaking News from FDA

This biotech company currently has an approved product on the market. However, there is more to the story than meets the eye.

The new drug Cobenfy promises to revolutionize treatment for schizophrenia with its novel mechanism, the first of its kind in decades.

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them

The Molekule Air Pro is the high-priced but undeniably high-quality air purifier I never knew I needed.

There's a new way to screen for high-risk HPV, a viral infection that can lead to cervical cancer. This alternative method of collecting samples for cervical cancer screening doesn't require a speculum.

With a robust performance, strategic expansions, and strong analyst endorsements, Eli Lilly appears poised for continued growth, making it a compelling investment opportunity.

Does tracking sleep lead to better rest? We take a long, long sleep with Samsung’s Galaxy Ring to determine what works and what doesn't — and what the science tells us.

People could previously get the nasal spray flu vaccine, called FluMist, from a health care provider, but now they can administer it themselves.

HP Hood and the FDA announced a voluntary recall of 96-ounce containers of Lactaid Milk on Sept. 20

Vaccine provides an alternative to flu shots administered with needles

The biotech industry is poised for significant growth, fueled by advanced technologies, the increased commercialization of new therapeutics, and increased R&D spending on treatments for new and rare diseases. Hence, investors should consider strong biotech stocks such as Amgen (AMGN), Regeneron Pharmaceuticals (REGN), and Biogen (BIIB), which could deliver big…